STAGE IIB BREAST CANCER
Clinical trials for STAGE IIB BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new STAGE IIB BREAST CANCER trials appear
Sign up with your email to follow new studies for STAGE IIB BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control Recruiting nowThis study tests a drug called trastuzumab deruxtecan, which delivers chemotherapy directly to cancer cells, alone or with anastrozole (a hormone blocker), for people with early-stage HER2 low, hormone receptor positive breast cancer. The goal is to see if the cancer disappears c…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE2 • Sponsor: Jonsson Comprehensive Cancer Center • Aim: Disease control
Last updated Jun 16, 2026 12:53 UTC
-
New drug aims to stop breast cancer spread before it starts
Disease control Recruiting nowThis study tests a drug called elacestrant in people with ER+/HER2- breast cancer whose blood tests show cancer DNA (ctDNA) but no clear spread. About 220 participants will either get elacestrant or continue their current hormone therapy. The goal is to see if elacestrant can del…
Matched conditions: STAGE IIB BREAST CANCER
Phase: PHASE3 • Sponsor: European Organisation for Research and Treatment of Cancer - EORTC • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC